Carregant...

Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV-1 protease

Drug resistance in HIV-1 protease, a barrier to effective treatment, is generally caused by mutations in the enzyme that disrupt inhibitor binding but still allow for substrate processing. Structural studies with mutant, inactive enzyme, have provided detailed information regarding how the substrate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Altman, Michael D., Nalivaika, Ellen A., Prabu-Jeyabalan, Moses, Schiffer, Celia A., Tidor, Bruce
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2802840/
https://ncbi.nlm.nih.gov/pubmed/17729291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prot.21514
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!